Apotek Hjartat
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|
Revenues | 14.2m | 7.0m | 7.5m | 7.9m | 8.0m |
% growth | - | (51 %) | 6 % | 6 % | 1 % |
EBITDA | (56.4m) | (57.9m) | - | - | - |
% EBITDA margin | (398 %) | (826 %) | - | - | - |
Profit | (106m) | (63.3m) | (61.3m) | (47.1m) | (77.9m) |
% profit margin | (751 %) | (903 %) | (822 %) | (596 %) | (980 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Early VC | |
$770m Valuation: $770m | Acquisition | ||
Total Funding | - |
Recent News about Apotek Hjartat
EditApotek Hjärtat is a prominent pharmacy chain in Sweden, catering to a wide range of customers including individuals seeking prescription medications, over-the-counter drugs, and health-related products. Operating in the healthcare and pharmaceutical market, the company provides a comprehensive selection of products through both physical stores and an online platform. The business model revolves around retail sales of medications and health products, as well as offering online consultations and prescription services. Revenue is generated through direct sales to consumers, leveraging both in-store and e-commerce channels. Apotek Hjärtat's strategic focus includes expanding its digital presence and enhancing customer convenience through services like e-prescriptions and home delivery.
Keywords: pharmacy, prescription, over-the-counter, health products, online consultations, e-commerce, digital services, Sweden, retail, healthcare.